CoRegen, Inc. funding
CoRegen, Inc., a biotechnology company based in Houston, TX (founded 2022), filed a Form D with the SEC on February 26, 2026 and reported $13.5M raised.
Amount raised$13.5M
Offering size$13.5M
Filed with the SECFebruary 26, 2026
First saleOctober 28, 2025
IndustryBiotechnology
SecuritiesEquity
LocationHouston, TX
Founded2022
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Feb 26
Other health care rounds in Texas
OncoNano Medicine, Inc.$10.1M · Oct 8BiotechnologySolaris Endovascular Inc.$5M · Oct 1BiotechnologyTransformer TX Holdings, LLC$4.1M · Nov 9Hospitals and PhysiciansTeos Health, LLC$3.1M · Oct 30Other Health CareCerenome, Inc.$3M · Sep 18Other Health CareFibroBiologics, Inc.$1.2M · Oct 13PharmaceuticalsPressio, Inc.$544K · Oct 6Other Health CareIctero Medical, Inc.$344K · Nov 5Other Health Care